Jennifer Straumins Sells 100,000 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 100,000 shares of the company's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00. Following the completion of the sale, the director now owns 1,084,589 shares of the company's stock, valued at $14,284,037.13. This represents a 8.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Calumet Specialty Products Partners Stock Performance

CLMT traded down $0.27 on Monday, hitting $13.17. The company had a trading volume of 536,468 shares, compared to its average volume of 935,134. The stock has a fifty day moving average price of $11.75 and a 200-day moving average price of $15.49. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -4.77 and a beta of 0.91. Calumet Specialty Products Partners, L.P. has a 12-month low of $7.68 and a 12-month high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The firm had revenue of $993.90 million during the quarter, compared to analyst estimates of $899.62 million. The business's revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.51) earnings per share. Analysts forecast that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on CLMT. The Goldman Sachs Group lowered their target price on Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating for the company in a report on Wednesday, April 30th. HC Wainwright reiterated a "buy" rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. Wells Fargo & Company decreased their price objective on Calumet Specialty Products Partners from $23.00 to $21.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and dropped their price objective for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, TD Cowen lowered Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and cut their target price for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $18.50.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.